Trial Profile
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2023
Price :
$35
*
At a glance
- Drugs PG 2 (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- Sponsors PhytoHealth
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 01 Aug 2017 Status changed from recruiting to completed.
- 09 May 2017 Planned number of patients changed from 250 to 350.